-
DEVELOPMENT AND VALIDATION OF A PREDICTION MODEL TO ESTIMATE THE HURLEY SCORE IN PATIENTS WITH HIDRADENITIS SUPPURATIVA
Aug 11, 2026, 17:16 PM -
CHARACTERIZING THE HUMANISTIC AND ECONOMIC BURDEN OF HYPOPHOSPHATASIA: A CROSS-SECTIONAL MULTINATIONAL STUDY IN CANADA, COLOMBIA, FRANCE, TURKEY AND THE UK
Aug 11, 2026, 17:16 PM -
SLEEP QUALITY, NONPRESCRIBED SLEEP AID USE, AND MEDICATION SAFETY AWARENESS AMONG UNIVERSITY STUDENTS IN SAUDI ARABIA
Aug 11, 2026, 17:16 PM -
CLINICAL AND ECONOMIC BURDEN OF HEMOLYTIC ANEMIA IN US PATIENTS WITH SICKLE CELL DISEASE: A REAL-WORLD ANALYSIS
Aug 11, 2026, 17:16 PM -
ADAPTING GLOBAL PATIENT-CENTERED RESEARCH METHODS TO JAPAN: A PRACTICAL FRAMEWORK FOR REGULATORY, ETHICAL, AND SITE-LEVEL IMPLEMENTATION
Aug 11, 2026, 17:16 PM -
LONG-TERM DEMENTIA RISK REDUCTION MAY IMPROVE THE COST-EFFECTIVENESS OF BLOOD PRESSURE LOWERING INTERVENTIONS INCLUDING RENAL DENERVATION
Aug 11, 2026, 17:16 PM -
AN END-TO-END QUALITY ASSURANCE FRAMEWORK FOR REGULATORY-GRADE REAL-WORLD EVIDENCE FROM MULTI-SOURCE ELECTRONIC HEALTH RECORDS
Aug 11, 2026, 17:16 PM -
NATIONAL BUDGET IMPACT ANALYSIS OF INTRODUCING COMBINED TRIPLE THERAPY (BUDESONIDE/ GLYCOPYRRONIUM/ FORMOTEROL FUMARATE) TO THE REIMBURSEMENT LIST FOR THE TREATMENT OF MODERATE-TO-SEVERE COPD IN ALGERIA
Aug 11, 2026, 17:16 PM -
EVALUATING AUTOMATED DEDUPLICATION: A PERFORMANCE COMPARISON OF EASYSLR AND ENDNOTE IN MULTI-DATABASE SYSTEMATIC LITERATURE REVIEWS
Aug 11, 2026, 17:16 PM -
ASSESSMENT OF DIETARY HABITS AMONG WOMEN DIAGNOSED WITH ENDOMETRIOSIS
Aug 11, 2026, 17:16 PM -
COST-UTILITY ANALYSIS OF SPARSENTAN FOR THE TREATMENT OF IMMUNOGLOBULIN A NEPHROPATHY: A COMPARISON OF SPARSENTAN VERSUS IRBESARTAN AND MODIFIED-RELEASE BUDESONIDE IN SPAIN
Aug 11, 2026, 17:16 PM -
STRUCTURED CARE PATHWAYS VERSUS HOME DELIVERY FOR TEMPERATURE-SENSITIVE BIOLOGICS IN IMMUNE-MEDIATED DISEASES: A REAL-WORLD PAYER ANALYSIS
Aug 11, 2026, 17:16 PM -
FROM APPROVAL TO ACCESS: TIME TO REIMBURSEMENT DECISION FOR BIOSIMILARS IN THE EU-4
Aug 11, 2026, 17:16 PM -
EPIDEMIOLOGICAL CHARACTERIZATION OF ATOPIC DERMATITIS IN COLOMBIA, 2021-2025: A DESCRIPTION OF THE INDIVIDUAL HEALTH SERVICE PROVISION RECORDS (RIPS)
Aug 11, 2026, 17:16 PM -
FRACTURE-RELATED COSTS OF HIGH-DOSE INTRAVENOUS IRON FORMULATION CHOICE: AUSTRIAN AND US REAL-WORLD EVIDENCE TRANSFERRED TO THE GERMAN HEALTHCARE SYSTEM
Aug 11, 2026, 17:16 PM -
REAL-WORLD PERSISTENCE AND SWITCHING PATTERNS AMONG FIRST-LINE AROMATASE INHIBITORS IN POSTMENOPAUSAL BREAST CANCER IN GREECE: EVIDENCE FROM THE NATIONAL E-PRESCRIPTION DATABASE (2020-2022)
Aug 11, 2026, 17:16 PM -
MAGELLAN HEALTH DATA WAREHOUSE: A METHODOLOGICAL FRAMEWORK FOR REAL-WORLD PATIENT POPULATION IDENTIFICATION ACROSS THERAPEUTIC AREAS
Aug 11, 2026, 17:16 PM -
CLINICAL AND ECONOMIC BURDEN OF HOSPITALIZATION FOR EXACERBATION OR CRISIS AMONG PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS IN THE UNITED STATES
Aug 11, 2026, 17:16 PM -
ASSESSING REPRODUCIBILITY OF REAL-WORLD EVIDENCE ANALYSES USING SYNTHETIC DATA: A VALIDATION STUDY IN RARE BRAF V600E METASTATIC NSCLC
Aug 11, 2026, 17:16 PM -
APPLYING THE KCE NEED FRAMEWORK TO CHARACTERIZE BURDEN AND UNMET NEED ACROSS UNDERSERVED AUTOIMMUNE DISEASES: A MULTI-STAKEHOLDER METHODS STUDY
Aug 11, 2026, 17:16 PM
